Research Summary
Analyzed using Evidence Intelligence™

Machine Learning Improves Glycemic Event Prediction in Diabetes

Last updated July 5, 2026

Key finding

Simulated evaluations confirmed improved postprandial time-in-range and reduced hypoglycemia.

This study explored a machine learning framework for predicting postprandial glycemic events in individuals with Type 1 Diabetes, demonstrating reductions in both hypoglycemia and hyperglycemia incidences.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study explored a machine learning framework for predicting postprandial glycemic events in individuals with Type 1 Diabetes, demonstrating reductions in both hypoglycemia and hyperglycemia incidences.

Clinical relevance

These findings highlight the potential of machine learning tools in managing Type 1 Diabetes, which can lead to better glycemic control and improved quality of life for patients. By reducing the risks associated with postprandial glycemic events, this approach may help prevent complications related to diabetes.

Keep in mind

Non-randomized design may introduce bias. Limited generalizability due to specific population characteristics. Effectiveness of the intervention remains unclear in broader contexts.

Published in

Journal Reference

Publication details and source links for this paper.

Najib UR, Ivan C, Aleix B, Josep V, Luiz OA. Explainable Machine Learning Framework for Predicting Postprandial Glycemic Events in Type 1 Diabetes. PLOS Digital Health. 2025;4(9):e0000996. doi:10.1371/journal.pdig.0000996

Main Effects

Postprandial hypoglycemia incidence reduced by 0.5 events (p=0.01).

Postprandial hyperglycemia incidence reduced by 0.4 events (p=0.02).

Mean blood glucose levels decreased by 10.5 mg/dL (p=0.001).

Time in range increased by 15% (p=0.005).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Insulin adjustment module and Blood glucose, Postprandial hyperglycemia incidence, Postprandial hypoglycemia incidence, and 1 more.

Primary intervention

Insulin adjustment module

Primary outcomes

  • Blood glucose
  • Postprandial hyperglycemia incidence
  • Postprandial hypoglycemia incidence

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

4
Evidence pairs
4
Relationships
1
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 63

1

Related topics

4

Evidence pairs

245

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 4 evidence relationships
  • Includes primary outcome data
  • Linked to 1 direct semantic evidence topic

Topic contributions

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence relationship

Smart Insulin Dosage Software and CGM Time in Range

Related evidence

Evidence relationship

Smart Insulin Dosage Software and Fasting Glucose

Save evidence

Evidence relationship

Smart Insulin Dosage Software and Hypoglycemia

Save evidence

Core evidence

Study findings

The primary outcomes reported in this study.

Blood glucose

Insulin adjustment module → Blood glucose

Insulin adjustment module → Blood glucose

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Postprandial hyperglycemia incidence

Insulin adjustment module → Postprandial hyperglycemia incidence

Insulin adjustment module → Postprandial hyperglycemia incidence

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Postprandial hypoglycemia incidence

Insulin adjustment module → Postprandial hypoglycemia incidence

Insulin adjustment module → Postprandial hypoglycemia incidence

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Time in range

Insulin adjustment module → Time in range

Insulin adjustment module → Time in range

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • Postprandial hypoglycemia incidence decreased by 0.5 events.
  • Mean blood glucose levels decreased significantly by 10.5 mg/dL.
  • Time in range improved by 15%.
who this applies

Who this applies to

  • Individuals with Type 1 Diabetes.
  • Patients experiencing postprandial glycemic fluctuations.
keep in mind

Keep in Mind

  • Results may not apply to all diabetes populations.
  • Further research needed to confirm findings in diverse settings.
  • The study did not measure long-term outcomes or complications.
between the lines

Between the Lines

  • Non-randomized design may introduce bias.
  • Limited generalizability due to specific population characteristics.
  • Effectiveness of the intervention remains unclear in broader contexts.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Smart Insulin Dosage Software and Fasting Glucose, Smart Insulin Dosage Software and Postprandial hyperglycemia incidence.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Smart Insulin Dosage Software improve cgm time in range?

Strong Evidence

Smart Insulin Dosage Software may worsen CGM Time in Range or be associated with harm.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Time in range

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on 3 supporting studies and existing graph evidence signals.

Limitations

  • Population details are unavailable.
3 supporting studiesUpdated: Jul 2026

Does Smart Insulin Dosage Software improve fasting glucose?

Moderate Evidence

Smart Insulin Dosage Software may improve Fasting Glucose.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Blood glucose

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.

Limitations

  • Only a small number of supporting studies are available.
  • Population details are unavailable.
2 supporting studiesUpdated: Jul 2026

Does Smart Insulin Dosage Software affect hypoglycemia?

Emerging Evidence

Current evidence does not show a clear benefit of Smart Insulin Dosage Software for Hypoglycemia.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Postprandial hypoglycemia incidence

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Insulin adjustment module improve postprandial hyperglycemia incidence?

Emerging Evidence

Current evidence does not show a clear benefit of Insulin adjustment module for Postprandial hyperglycemia incidence.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Postprandial hyperglycemia incidence

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.